| Target Price | CHF285.60 |
| Price | CHF228.00 |
| Potential |
25.26%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target HBM Healthcare Investments 2027 .
The average HBM Healthcare Investments target price is CHF285.60.
This is
25.26%
register free of charge
CHF294.00
28.95%
register free of charge
CHF282.80
24.04%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend HBM Healthcare Investments to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the HBM Healthcare Investments stock has an average upside potential 2027 of
25.26%
register free of charge
|
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Million CHF | 297.06 | 314.16 |
| 607.12% | 5.76% | |
| Net Margin | 91.51% | 98.52% |
| 107.36% | 7.66% |
3 Analysts have issued a sales forecast HBM Healthcare Investments 2027 . The average HBM Healthcare Investments sales estimate is
This results in the following potential growth metrics:
3 HBM Healthcare Investments Analysts have issued a net profit forecast 2027. The average HBM Healthcare Investments net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 40.74 | 46.90 |
| 1,397.79% | 15.12% | |
| P/E | 4.86 | |
| EV/Sales | 5.43 |
3 Analysts have issued a HBM Healthcare Investments forecast for earnings per share. The average HBM Healthcare Investments EPS is
This results in the following potential growth metrics and future valuations:
HBM Healthcare Investments...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BAADER EUROPE |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Jun 18 2026 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Jun 17 2026 |
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jan 23 2026 |
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jan 22 2026 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Dec 15 2025 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Oct 13 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BAADER EUROPE:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Jun 18 2026 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Jun 17 2026 |
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Jan 23 2026 |
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Jan 22 2026 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Dec 15 2025 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Oct 13 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


